Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 4 NETWORK 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 16 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Osteosarcoma 1 Neoplasms 1 Neoplasm, Residual 1 Leiomyosarcoma 1 Ganglioneuroblastoma 1 Bone Neoplasms 1

Interventions

gallium Ga 68 dotatate 1 dinutuximab 1 Temozolomide 1 Proton Therapy 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Ga(III)-DOTATOC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Ganglioneuroblastoma × dinutuximab × Clear all

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡